Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
CE Holdings Co., Ltd. (4320.T)
Sapporo, JP
CE Holdings Co., Ltd., operating through its subsidiaries in Japan, specializes in the development and sale of electronic medical record (EMR) and comprehensive medical information systems. Its product portfolio includes MI RA Is (Miraize), a notable EMR system tailored for healthcare facilities. The entity, initially known as CEI Corporation, rebranded to CE Holdings Co., Ltd. in April 2013. Established in 1996, the company maintains its headquarters in Sapporo, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.42% | +0.33% | -0.33% | -4.76% | +20.10% | +14.60% | +77.14% | +113.32% | +117.18% | +430.24% | +2.21% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Healthcare Information Services: +14.2%+8.8% Q1'26: +7.7% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+1,107.0% ★ Q1'26: -39.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+4.3% Q1'26: +5.8% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+8.9% ★ Q1'26: +12.8% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%+19.7% ★ Q1'26: +53.7% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+4.6% Q1'26: +9.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×0.74× ★ Q1'26: 0.55× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2020 actual |
Sep 2021 actual |
|---|---|---|
| Revenue |
10.60B
est: 11.70B (-9.4%)
|
12.28B
est: 12.50B (-1.7%)
|
| EBITDA |
907.11M
est: 1.42B (-36.1%)
|
1.23B
est: 1.52B (-19.2%)
|
| EBIT |
547.07M
est: 1.05B (-47.8%)
|
879.06M
est: 1.12B (-21.5%)
|
| Net Income |
121.45M
|
632.93M
|
| SGA |
1.33B
est: 521.73M (+155.6%)
|
1.53B
est: 557.40M (+174.5%)
|
| EPS |
8.10
|
42.34
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-07 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-01 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-30 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-28 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-27 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 4/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-22 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-21 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-20 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-17 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-16 | A | 4/5 | 4/5 | 5/5 | 5/5 | 2/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Value ETF AVDV | 0.00% | 123.8K | 0.36% |
| 2 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 51.1K | 0.28% |
| 3 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 18.4K | 0.22% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Keiaki Sugimoto | Chairman & Chief Executive Officer | — | male |
| Keiichi Haga | MD, Chief Strategy Officer & Director | — | male |
| Masanori Niisato | President, COO & Representative Director | — | male |
| Tsunehito Taguchi | Chief Financial Officer & Director | — | male |
| Yoshitaka Matsuzawa | Senior MD, Chief Risk Officer & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4320.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
